IR-Med Inc.
IRME · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $33 | $80 | $34 | $139 |
| - Cash | $0 | $1 | $3 | $3 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $33 | $79 | $31 | $136 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$5 | -$5 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$5 | -$9 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.027 | -0.071 | -0.14 | -0.059 |
| % Growth | 62% | 49.5% | -137.3% | – |
| Operating Cash Flow | -$1 | -$3 | -$3 | -$2 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$3 | -$3 | -$3 |